Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,858,756 papers from all fields of science
Search
Sign In
Create Free Account
reveromycin A
Known as:
reveromycin
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Pyrans
Spiro Compounds
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Identification of Middle Chain Fatty Acyl-CoA Ligase Responsible for the Biosynthesis of 2-Alkylmalonyl-CoAs for Polyketide Extender Unit*
T. Miyazawa
,
Shunji Takahashi
,
+5 authors
H. Osada
Journal of Biological Chemistry
2015
Corpus ID: 20256645
Background: Fatty acyl-CoA ligases involved in polyketide biosynthesis remain uncharacterized. Results: RevS classified in fatty…
Expand
2012
2012
Effect of Reveromycin A on Experimental Tooth Movement in OPG−/− Mice
M. Tanaka
,
K. Miyazawa
,
+8 authors
S. Goto
Journal of dentistry research
2012
Corpus ID: 46204965
In osteoprotegerin-deficient (OPG−/−) mice, osteoclast activity causes bone resorption to outpace bone formation, leading to the…
Expand
2012
2012
Creation of novel reveromycin derivatives by alcohol-added fermentation
T. Nogawa
,
Shunji Takahashi
,
+6 authors
H. Osada
Journal of antibiotics (Tokyo. )
2012
Corpus ID: 5910433
Reveromycin A, a polyketide compound with a distinctive spiroacetal core structure (Figure 1), was isolated from Streptomyces…
Expand
Review
2008
Review
2008
Pharmacological topics of bone metabolism: antiresorptive microbial compounds that inhibit osteoclast differentiation, function, and survival.
J. Woo
,
T. Yonezawa
,
Byung‐Yoon Cha
,
T. Teruya
,
K. Nagai
Journal of Pharmacological Sciences
2008
Corpus ID: 7432050
The mass and function of bones depends on the maintenance of a complicated balance between osteoclast-mediated bone resorption…
Expand
2002
2002
Reveromycin A inhibits antigen receptor-mediated antigen presentation by B lymphoma cells via its effect on intracellular trafficking of the antigen.
Yuriko Tanaka
,
F. Ishikawa
,
H. Osada
,
S. Imajoh‐ohmi
,
T. Uchida
,
T. Kakiuchi
Journal of antibiotics (Tokyo. )
2002
Corpus ID: 40014604
Reveromycin A (Rev.A) is an inhibitor of epidermal growth factor-dependent cell growth that is produced from the culture broth of…
Expand
2002
2002
Chemical modification of reveromycin A and its biological activities.
Takeshi Shimizu*
,
T. Usui
,
K. Machida
,
K. Furuya
,
H. Osada
,
T. Nakata
Bioorganic & Medicinal Chemistry Letters
2002
Corpus ID: 34678311
2001
2001
Total synthesis of the epidermal growth factor inhibitor (-)-reveromycin B.
A. Cuzzupe
,
C. Hutton
,
+4 authors
M. Rizzacasa
Journal of Organic Chemistry
2001
Corpus ID: 22699698
The total synthesis of the epidermal growth factor inhibitor reveromycin B (2) in 25 linear steps from chiral methylene pyran 13…
Expand
2000
2000
Stereoselective total synthesis of reveromycin B and C19-epi-reveromycin B.
K. Drouet
,
E. Theodorakis
Chemistry
2000
Corpus ID: 1222012
Our studies toward the total synthesis of the reveromycin family of natural products are described herein. Our synthetic approach…
Expand
2000
2000
Total synthesis of reveromycin A.
T. Shimizu
,
T. Masuda
,
K. Hiramoto
,
T. Nakata
Organic Letters
2000
Corpus ID: 149463
The stereoselective total synthesis of reveromycin A (1), a potent inhibitor of eukaryotic cell growth, has been accomplished on…
Expand
2000
2000
Enantioselective synthesis of the [6,6] spiroketal core of reveromycin A.
K. Drouet
,
T. Ling
,
H. V. Tran
,
E. Theodorakis
Organic Letters
2000
Corpus ID: 32785833
[structure: see text] Reveromycin A (1) belongs to a family of microbial polyketides with unusual structural features and…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE